A compound comprising one or more CD1d complexes and an antibody or its fragment specific for a cell surface marker, is new. The CD1d complexes comprise a CD1d and a beta 2-microglobulin molecule, and are linked to the antibody or its fragment. Independent claims are also included for the following: (1) a method for inducing an anti-tumor response in a mammal, comprising administering the above compound to the mammal and (2) methods of preventing or treating autoimmune/inflammatory or infectious disease in a mammal, comprising administering the above compound to the mammal. ACTIVITY : Cytostatic Antiinflammatory Immunosuppressive Antimicrobial Neuroprotective Antidiabetic Antiarthritic Antirheumatic Ophthalmological Gastrointestinal-Gen. Nephrotropic Antithyroid Thyromimetic Muscular-Gen. Antipsoriatic Dermatological Antianemic Hepatotropic Antiulcer. No biological data given. MECHANISM OF ACTION : Antibody therapy.
